Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To evaluate the state of psychology and quality of life of patients effected by acne and also the efficacy and safety of photodynamic therapy with topical 5-aminolevulinic acid (ALA-PDT) for moderate to severe acne patients.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>In the questionnaire part, a pre-designed form was filled out. The questionnaire was comprised of 2 sections related to acne including sociodemographic and disease information as well as Cardiff Acne Disability Index (CADI) and Self-Rating Anxiety Scale (SAS). In the trial part, the ALA-PDT was applied to moderate to severe acne patients. Fresh 5% ALA solution was topically applied to face or face & neck. After 1 h's incubation, a LED device was illuminated. A power density of 60−100 mW/cm<sup>2</sup> was delivered for 20 min. All the patients finished 3–4 sessions of ALA-PDT at 7–10 days intervals. Non-invasive detections were taken for skin moisture, oil, and VISIA indexes. Adverse events were recorded during and after the treatment.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>A total of 247 acne patients finished questionnaires. Over 97 % patients were assessed as mild to severe impacts in CADI questionnaire and 37.6 % patients had various degrees of anxiety in SAS questionnaire. The higher the BMI was, the higher the CADI points were (G = 0.278, <em>p</em> = 0.005). The severity of acne was correlated with psychology and quality of life (CADI: G = 0.367, <em>p</em> = 0.000; SAS: G = 0.285, <em>p</em> = 0.003). A total of 116 patients with moderate or severe acne accepted ALA-PDT and completed at least 3 sessions (PDT3) or even PDT4. After 1 session of treatment (AT1) and AT2, the efficiencies of all patients were 5.2 % and 29.3 %. For patients with PDT3, the efficiencies at follow-up at 1st month after last session (FU1), FU2 and FU3 were 59.4 %, 66.7 % and 78.3 %, respectively. For patients with PDT4, the efficiencies at AT3 and FU1–3 were 51.3 %, 63.6 %, 76.5 % and 85.7 %, respectively. The efficacies of PDT4 patients showed an increasing trend from FU1 to FU3 (G = 0.480, <em>p</em> = 0.004). Acne lesions of mild to severe were correlated with the treatment efficacies (FU1: G = 0.354, <em>p</em> = 0.000; FU2: G = 0.474, <em>p</em> = 0.000; FU3: G = 0.397, <em>p</em> = 0.000). Nearly 15 % patients were followed up for 12 months and among them 52.9 % patients were able to maintain ≥90 % improvement rate. There were no statistically significant differences before and after treatment (<em>p</em> > 0.05) according to the skin moisture content, oil content, ultraviolet ray spots, brown spots, red areas, and purple textures measured. The adverse reactions of ALA-PDT, including local burning sensation, mild pain sensation, mild edema erythema, reactive acne, pigmentation, etc., were temporary and tolerable.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>In our study, 97.2 % patients were rated as impact in CADI questionnaire and 37.6 % patients had anxiety in SAS questionnaire. It is necessary to control weight and disease progression. The efficiencies of ALA-PDT for moderate and severe acne were 59.4%–85.7% at follow-ups of 1st, 2nd or 3rd month after last session. The adverse reactions of ALA-PDT were temporary and tolerable.</p>

The clinical research of three treatment methods of 5-aminolevulinic acid photodynamic therapy for moderate to severe acne

Analysis of Efficacy and Safety of 5-Aminolevulinic Acid-Mediated Photodynamic Therapy in the Treatment of ;Moderate to Severe Acne

Topical aminolevulinic acid-photodynamic therapy in acne

Therapeutic effect and follow-up analysis of photodynamic therapy in the treatment of moderate to severe acne

Low-dose Topical 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Different Severity of Acne Vulgaris.

The Efficacy Treatment of Topical Aiminolevulinic Acid Photodynamic on Cystic Acne Therapy

Topical Application Of Ala Pdt For The Treatment Of Moderate To Severe Acne Vulgaris

Photodynamic therapy with different concentrations of 5-aminolevulinic acid in the treatment of cystic acne

Efficacy of 3.6% Topical ALA-PDT for the Treatment of Severe Acne Vulgaris.

The assessment of psychology, quality of life in acne patients and evaluation of ALA-PDT for moderate to severe acne

5-aminolevulinic acid photodynamic therapy using 560-1200 nm followed by 420-1200 nm broadband light in the treatment of moderate-to-severe acne

Prospective Study of Topical 5-Aminolevulinic Acid Photodynamic Therapy for the Treatment of Moderate to Severe Acne Vulgaris in Chinese Patients

A Prospective Study of Adverse Reactions of ALA-PDT for Acne Vulgaris

Study of different pre-treatments in the comparison of the efficacy of photodynamic therapy for moderate to severe acne vulgaris

Clinical practice Guidelines for 5-Aminolevulinic acid photodynamic therapy for acne vulgaris in China

Efficacy and Therapeutic Reactions of Tri-Needle-pretreatment Combined with Painless ALA-PDT for the Treatment of Moderate-to-severe Acne Vulgaris: a Randomized Controlled Trial

Topical photodynamic therapy with 5-aminolevulinic acid in Chinese patients with Rosacea.

Nursing Experience of Photodynamic Therapy with Topical 5-Aminolevulinic Acid in Moderate-severe Acne

Topical 5-Aminolevulinic Acid-Mediated Photodynamic Therapy for Oral Verrucous Hyperplasia, Oral Leukoplakia and Oral Erythroleukoplakia

Topical 5-Aminolevulinic Photodynamic Therapy with Red Light Vs Intense Pulsed Light for the Treatment of Acne Vulgaris: A Spilit Face, Randomized, Prospective Study

IPL-PDT As an Effective Treatment for Mild-to-moderate Acne Vulgaris: A Prospective, Single-Center, Self-Controlled Study.